Compounds > cladribine
Page last updated: 2024-08-22

cladribine and Central Nervous System Diseases

cladribine has been researched along with Central Nervous System Diseases in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (28.57)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Atkins, HL; Bergman, H; Brooks, J; Freedman, MS; Thebault, S1
Kasahara, I; Sakai, T; Wada, N; Yamaguchi, K; Yamamoto, S1
Kasami, T; Katagiri, T; Kawamoto, K; Kobayashi, H; Masuko, M; Miyakoshi, S; Miyoshi, H; Nemoto, H; Ohshima, K; Shibasaki, Y; Sone, H; Suzuki, T; Takeuchi, K; Takizawa, J; Tamura, S1
Bhagwan, B; Bhagwan, S; Bhigjee, AI1
Duncan, A; Parslew, R; Pizer, BL; Rajendra, B1
Baumann, M; Cerny, T; Koeberle, D; Sommacal, A1
Allen, JC; Arceci, RJ; Dhall, G; Dunkel, IJ; Egeler, RM; Ettinger, LJ; Finlay, JL; Kellie, SJ1

Other Studies

7 other study(ies) available for cladribine and Central Nervous System Diseases

ArticleYear
CLIPPERS Responsive to Cladribine as a Durable Steroid-Sparing Agent.
    Neurology(R) neuroimmunology & neuroinflammation, 2023, Volume: 10, Issue:1

    Topics: Adult; Central Nervous System Diseases; Cladribine; Humans; Magnetic Resonance Imaging; Male; Pons; Prednisone

2023
[Refractory Erdheim-Chester disease with central nervous system lesion complicated by central diabetes insipidus].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2020, Volume: 61, Issue:10

    Topics: Central Nervous System; Central Nervous System Diseases; Cladribine; Diabetes Insipidus, Neurogenic; Erdheim-Chester Disease; Female; Humans; Middle Aged; Tomography, X-Ray Computed

2020
Cladribine treatment for Erdheim-Chester disease involving the central nervous system and concomitant polycythemia vera: A case report.
    Journal of clinical and experimental hematopathology : JCEH, 2018, Dec-13, Volume: 58, Issue:4

    Topics: Aged; Amino Acid Substitution; Central Nervous System Diseases; Cladribine; Erdheim-Chester Disease; Humans; Janus Kinase 2; Male; Mutation, Missense; Polycythemia Vera; Proto-Oncogene Proteins B-raf

2018
The use of cladribine in neurosarcoidosis: A report of two cases.
    Clinical neurology and neurosurgery, 2015, Volume: 136

    Topics: Adult; Brain; Central Nervous System Diseases; Cladribine; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Sarcoidosis; Spinal Cord; Treatment Outcome

2015
Successful treatment of central nervous system juvenile xanthogranulomatosis with cladribine.
    Pediatric blood & cancer, 2009, Volume: 52, Issue:3

    Topics: Central Nervous System Diseases; Cladribine; Follow-Up Studies; Humans; Infant; Male; Tomography, X-Ray Computed; Xanthogranuloma, Juvenile

2009
Langerhans cell histiocytosis with central nervous system involvement--complete response to 2-chlorodeoxyadenosine after failure of tyrosine kinase inhibitor therapies with sorafenib and imatinib.
    Hematological oncology, 2012, Volume: 30, Issue:2

    Topics: Adult; Antineoplastic Agents; Benzamides; Benzenesulfonates; Central Nervous System Diseases; Cladribine; Histiocytosis, Langerhans-Cell; Humans; Imatinib Mesylate; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Sorafenib

2012
Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
    Pediatric blood & cancer, 2008, Volume: 50, Issue:1

    Topics: Adolescent; Adult; Central Nervous System Diseases; Child; Child, Preschool; Cladribine; Female; Histiocytosis, Langerhans-Cell; Humans; Immunosuppressive Agents; Male; Middle Aged; Remission Induction

2008